Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cryomass Technologies Inc

Healthcare US CRYM

0.0002USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.00010.03
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.05M
  • Volume15950
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.54732M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.04M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -12.93394M -10.44448M -10.13464M -6.86044M -3.03056M
Minority interest - - - - -
Net income -12.95573M -10.42269M -12.85964M -11.81591M -3.05753M
Selling general administrative 5.61M 10.13M 7.95M 6.57M 3.57M
Selling and marketing expenses - - - - -
Gross profit 0.01M 0.00000M 0.00000M 0.04M 1.04M
Reconciled depreciation 0.33M 0.16M 0.04M - 0.15M
Ebit - - -7.99183M -6.53484M -3.33293M
Ebitda - -10.13506M -7.90102M -6.62353M -2.87214M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -5.93905M -10.31181M -7.99183M -6.53484M -3.02052M
Other operating expenses - - - - -
Interest expense 0.39M 0.15M 2.19M 0.24M 0.01M
Tax provision 0.02M -0.02179M 0.00000M 0.01M 0.00469M
Interest income - - - - -
Net interest income -0.38891M -0.14701M -2.18996M -0.23691M -0.01270M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 0.01M 0.00469M
Total revenue 0.01M 0.00000M 0.00000M 0.78M 3.48M
Total operating expenses 5.95M 10.31M 7.99M 7.32M 6.50M
Cost of revenue 0.00000M 0.00000M 0.00000M 0.74M 2.44M
Total other income expense net -6.60598M 0.01M 0.05M -0.08869M 0.00266M
Discontinued operations - - -2.72500M -4.95546M 0.28M
Net income from continuing ops -12.95573M -10.42269M -10.13464M -6.87068M -3.03525M
Net income applicable to common shares - - -12.85964M -11.81591M -3.05753M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 0.97M 7.86M 15.58M 7.80M 16.07M
Intangible assets 0.10M 3.98M 4.04M - 2.87M
Earning assets - - - - -
Other current assets - - - 6.87M 11.85M
Total liab 6.82M 3.29M 2.06M 4.19M 2.34M
Total stockholder equity -5.84924M 4.57M 13.52M 3.61M 12.44M
Deferred long term liab - - - - -
Other current liab - - 0.00077M 1.47M 1.91M
Common stock - - 0.20M 0.10M 0.11M
Capital stock 0.21M 0.20M 0.20M 0.10M 0.11M
Retained earnings -51.96726M -39.01153M -28.58884M -15.72919M -3.91329M
Other liab - - - 0.01M 0.00469M
Good will 0.00000M 1.19M 1.19M - 5.86M
Other assets - - 3.60M - -
Cash 0.05M 2.02M 5.77M 0.33M 3.47M
Cash and equivalents - - - - -
Total current liabilities 2.49M 1.29M 1.88M 4.13M 2.67M
Current deferred revenue - - - - -
Net debt 3.26M - - 0.13M -
Short term debt - - - - -
Short long term debt 0.24M - - 0.41M 0.31M
Short long term debt total - - - - -
Other stockholder equity - - - 0.10M -
Property plant equipment - - 0.23M - -
Total current assets 0.15M 2.17M 6.53M 7.80M 15.76M
Long term investments - - - - -
Net tangible assets - - 8.30M 3.61M 13.09M
Short term investments - - - - -
Net receivables 0.00855M - 0.00000M 0.54M -
Long term debt 3.07M 2.00M 0.18M 0.05M -
Inventory - - - 0.00000M 0.34M
Accounts payable - - 1.88M 2.25M 0.75M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.82M 5.70M 9.05M 0.00000M 12.14M
Capital lease obligations - - - - 1.24M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.07424M -1.01867M -2.80324M -0.69325M -1.89969M
Change to liabilities - - -0.36659M 1.49M 0.69M
Total cashflows from investing activities - - -2.80324M -0.69325M -1.89969M
Net borrowings 1.38M - 3.03M 0.66M 0.66M
Total cash from financing activities 1.91M 2.03M 13.85M 1.30M 7.00M
Change to operating activities - - -0.69691M 0.04M -0.10833M
Net income -12.95573M -10.42269M -12.85964M -11.81591M -3.05753M
Change in cash -1.96683M -3.75678M 5.44M -3.14393M 3.31M
Begin period cash flow 2.02M 5.77M 0.33M 3.47M 0.17M
End period cash flow 0.05M 2.02M 5.77M 0.33M 3.47M
Total cash from operating activities -3.80498M -4.76686M -5.60051M -3.74962M -1.79532M
Issuance of capital stock 0.39M 0.28M 10.31M 0.64M 7.10M
Depreciation 0.33M 0.16M 0.04M 0.13M 0.13M
Other cashflows from investing activities - - -1.57824M -0.69325M -0.04108M
Dividends paid - - - - -
Change to inventory - - 0.00000M -0.06079M -0.50380M
Change to account receivables -0.00855M - 0.00000M -0.54000M -0.54000M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - 0.51M 0.51M -0.10000M
Change to netincome - - 6.73M 6.95M 1.19M
Capital expenditures 0.07M 0.40M 1.23M 1.23M 1.23M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.85M 0.03M -1.06350M 0.93M 0.09M
Stock based compensation 0.25M 0.60M 2.65M 1.44M -
Other non cash items 1.13M 0.66M 2.88M 0.06M 0.87M
Free cash flow -3.87922M -5.16670M -5.82551M -3.74962M -1.83314M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRYM
Cryomass Technologies Inc		 - -% 0.0002 - - 1.26 2.83 84.50 -3.8382
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.

Cryomass Technologies Inc

1001 Bannock Street, Denver, CO, United States, 80204

Key Executives

Name Title Year Born
Mr. Christian Noel CEO & Director 1977
Mr. Philip Blair Mullin B.A., BA, M.B.A., MBA Chief Financial Officer 1954
Ms. Patricia I. Kovacevic Gen. Counsel, Corp. Sec. & Head of External Affairs 1971
Mr. Ryan Smith Chief Operating Officer of Good Meds NA
Mr. Stephen Schroeder Consultant NA
Ms. Caroline Lenardon Consultant NA
Ms. Janice Matthews Consultant NA
Mr. Philip Blair Mullin B.A., M.B.A. Chief Financial Officer 1954
Ms. Patricia I. Kovacevic General Counsel, Corporate Secretary & Head of External Affairs 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.